This report was recently updated on December 16 2024 with the latest and most recent
market numbers
Global Weight Loss Drugs Market Size, Trends & Analysis - Forecasts to 2029 By Drug Type (Prescription and Over-the-counter), By Application (Appetite Suppression, Fat Blocking, and Others), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global weight loss drugs market is analyzed to grow at a CAGR of 21.2% during the forecast period of 2024 to 2029. Weight loss drugs work through various mechanisms in the body to promote weight loss, such as reducing appetite, increasing feelings of fullness, decreasing absorption of nutrients, or increasing calorie expenditure.
The weight loss drugs market is propelled by the escalating global obesity crisis and increasing societal emphasis on health and wellness. As obesity rates surge worldwide, there is a heightened demand for effective weight management solutions. Concurrently, a cultural shift towards prioritizing health and fitness encourages individuals to seek tools to achieve and maintain a healthy weight. These intertwined factors create a robust market for weight loss drugs, motivating pharmaceutical companies to innovate and develop new treatments to address the pressing need for effective weight management solutions. One significant opportunity in the global weight loss and anti-obesity drugs market lies in developing personalized medicine approaches. As scientific understanding of genetics, metabolism, and individual responses to medications advances, there is a growing potential to tailor weight loss treatments to each person's unique biology.
A major restraint of the market revolves around safety concerns, potential side effects, and regulatory hurdles, which are significant factors that pharmaceutical companies must navigate when developing and marketing weight loss medications.
Based on drug type, the market is segmented into prescription and over-the-counter. The prescription segment is expected to hold the largest share of the market during the forecast period. Rising investments in research and development are driving the uptake of these products, while a rise in prescriptions from healthcare providers is fueling sales of prescription medications. Furthermore, the anticipated introduction of new prescription drugs during the forecast period is expected to solidify the dominance of this segment in the global market.
The over-the-counter segment is projected to grow fastest during the forecast period. This surge is attributed to increased consumer awareness and demand for accessible weight loss solutions without the need for prescriptions. Additionally, advancements in over-the-counter formulations and marketing strategies are likely to contribute to the segment's accelerated expansion in the market.
Based on application, the market is segmented into appetite suppression, fat blocking, and others. The appetite suppression segment is expected to hold the largest share of the market during the forecast period. The growth can be attributed to its widespread adoption and proven efficacy in curbing hunger cravings. Appetite-suppressing medications are widely prescribed and favored by individuals seeking to reduce calorie intake and control their eating habits. Their ability to help individuals feel fuller for extended periods contributes to their popularity and widespread use in weight management strategies.
The fat blocking segment is projected to grow fastest during the forecast period. This surge can be attributed to the increasing demand for medications that inhibit the absorption of dietary fats, coupled with advancements in lipase inhibitor drugs. These factors contribute to the segment's accelerated expansion as an effective solution for weight management.
North America is analyzed to be the largest region in the global weight loss drugs market during the forecast period. This dominance is attributed to factors such as high obesity rates, increasing health consciousness, robust healthcare infrastructure, and significant investments in research and development within the region.
Asia Pacific is analyzed to be the fastest-growing region in the weight loss drugs market during the forecast period. Demand for weight loss medications is propelled by escalating obesity rates in countries like China and India. Higher disposable incomes enable a broader demographic to access and afford these medications. Increasing health and wellness awareness encourages more individuals to embrace weight management solutions. The growth of the pharmaceutical sector, improved healthcare infrastructure, and the entry of multinational pharmaceutical firms through strategic partnerships support market growth.
Novo Nordisk A/S, Eli Lilly & Co., Amgen Inc., Pfizer Inc., Viking Therapeutics Inc., Structure Therapeutics Inc., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, and Sandoz International GmbH, among others, are some of the key players operating in the global market.
Please note: This is not an exhaustive list of companies profiled in the report.
In March 2024, Novo Nordisk announced that its new drug amycretin for fighting against obesity is performing better than its previous drug, Wegovy, in the trials.
In November 2023, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL WEIGHT LOSS DRUGS MARKET, BY DRUG TYPE
4.1 Introduction
4.2 Weight Loss Drugs Market: Drug Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Prescription
4.4.1 Prescription Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Over-the-counter
4.5.1 Over-the-counter Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL WEIGHT LOSS DRUGS MARKET, BY APPLICATION
5.1 Introduction
5.2 Weight Loss Drugs Market: Application Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Appetite Suppression
5.4.1 Appetite Suppression Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Fat Blocking
5.5.1 Fat Blocking Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Others
5.6.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL WEIGHT LOSS DRUGS MARKET, BY REGION
6.1 Introduction
6.2 North America Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Drug Type
6.2.2 By Application
6.2.3 By Country
6.2.3.1 U.S. Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Drug Type
6.2.3.1.2 By Application
6.2.3.2 Canada Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Drug Type
6.2.3.2.2 By Application
6.2.3.3 Mexico Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Drug Type
6.2.3.3.2 By Application
6.3 Europe Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Drug Type
6.3.2 By Application
6.3.3 By Country
6.3.3.1 Germany Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Drug Type
6.3.3.1.2 By Application
6.3.3.2 U.K. Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Drug Type
6.3.3.2.2 By Application
6.3.3.3 France Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Drug Type
6.3.3.3.2 By Application
6.3.3.4 Italy Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Drug Type
6.3.3.4.2 By Application
6.3.3.5 Spain Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Drug Type
6.3.3.5.2 By Application
6.3.3.6 Netherlands Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Drug Type
6.3.3.6.2 By Application
6.3.3.7 Rest of Europe Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Drug Type
6.3.3.6.2 By Application
6.4 Asia Pacific Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Drug Type
6.4.2 By Application
6.4.3 By Country
6.4.3.1 China Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Drug Type
6.4.3.1.2 By Application
6.4.3.2 Japan Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Drug Type
6.4.3.2.2 By Application
6.4.3.3 India Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Drug Type
6.4.3.3.2 By Application
6.4.3.4 South Korea Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Drug Type
6.4.3.4.2 By Application
6.4.3.5 Singapore Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Drug Type
6.4.3.5.2 By Application
6.4.3.6 Malaysia Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Drug Type
6.4.3.6.2 By Application
6.4.3.7 Thailand Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Drug Type
6.4.3.6.2 By Application
6.4.3.8 Indonesia Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Drug Type
6.4.3.7.2 By Application
6.4.3.9 Vietnam Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Drug Type
6.4.3.8.2 By Application
6.4.3.10 Taiwan Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Drug Type
6.4.3.10.2 By Application
6.4.3.11 Rest of Asia Pacific Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Drug Type
6.4.3.11.2 By Application
6.5 Middle East and Africa Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Drug Type
6.5.2 By Application
6.5.3 By Country
6.5.3.1 Saudi Arabia Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Drug Type
6.5.3.1.2 By Application
6.5.3.2 U.A.E. Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Drug Type
6.5.3.2.2 By Application
6.5.3.3 Israel Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Drug Type
6.5.3.3.2 By Application
6.5.3.4 South Africa Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Drug Type
6.5.3.4.2 By Application
6.5.3.5 Rest of Middle East and Africa Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Drug Type
6.5.3.5.2 By Application
6.6 Central & South America Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Drug Type
6.6.2 By Application
6.6.3 By Country
6.6.3.1 Brazil Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Drug Type
6.6.3.1.2 By Application
6.6.3.2 Argentina Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Drug Type
6.6.3.2.2 By Application
6.6.3.3 Chile Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Drug Type
6.6.3.3.2 By Application
6.6.3.3 Rest of Central & South America Weight Loss Drugs Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Drug Type
6.6.3.3.2 By Application
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Novo Nordisk A/S
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Eli Lilly & Co.
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Amgen Inc.
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Pfizer Inc.
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Viking Therapeutics Inc.
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 STRUCTURE THERAPEUTICS INC.
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 F. Hoffmann-La Roche Ltd
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Teva Pharmaceutical Industries Ltd.
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 GlaxoSmithKline plc
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Sandoz International GmbH
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
2 Prescription Market, By Region, 2021-2029 (USD Million)
3 Over-the-counter Market, By Region, 2021-2029 (USD Million)
4 Global Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
5 Appetite Suppression Market, By Region, 2021-2029 (USD Million)
6 Fat Blocking Market, By Region, 2021-2029 (USD Million)
7 Others Market, By Region, 2021-2029 (USD Million)
8 Regional Analysis, 2021-2029 (USD Million)
9 North America Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
10 North America Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
11 North America Weight Loss Drugs Market, By Country, 2021-2029 (USD Million)
12 U.S. Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
13 U.S. Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
14 Canada Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
15 Canada Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
16 Mexico Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
17 Mexico Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
18 Europe Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
19 Europe Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
20 Europe Weight Loss Drugs Market, By Country, 2021-2029 (USD Million)
21 Germany Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
22 Germany Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
23 U.K. Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
24 U.K. Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
25 France Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
26 France Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
27 Italy Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
28 Italy Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
29 Spain Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
30 Spain Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
31 Netherlands Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
32 Netherlands Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
33 Rest Of Europe Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
34 Rest Of Europe Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
35 Asia Pacific Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
36 Asia Pacific Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
37 Asia Pacific Weight Loss Drugs Market, By Country, 2021-2029 (USD Million)
38 China Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
39 China Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
40 Japan Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
41 Japan Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
42 India Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
43 India Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
44 South Korea Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
45 South Korea Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
46 Singapore Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
47 Singapore Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
48 Thailand Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
49 Thailand Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
50 Malaysia Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
51 Malaysia Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
52 Indonesia Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
53 Indonesia Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
54 Vietnam Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
55 Vietnam Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
56 Taiwan Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
57 Taiwan Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
58 Rest of APAC Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
59 Rest of APAC Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
60 Middle East and Africa Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
61 Middle East and Africa Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
62 Middle East and Africa Weight Loss Drugs Market, By country, 2021-2029 (USD Million)
63 Saudi Arabia Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
64 Saudi Arabia Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
65 UAE Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
66 UAE Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
67 Israel Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
68 Israel Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
69 South Africa Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
70 South Africa Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
71 Rest Of Middle East and Africa Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
72 Rest Of Middle East and Africa Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
73 Central & South America Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
74 Central & South America Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
75 Central & South America Weight Loss Drugs Market, By Country, 2021-2029 (USD Million)
76 Brazil Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
77 Brazil Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
78 Chile Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
79 Chile Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
80 Argentina Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
81 Argentina Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
82 Rest Of Central & South America Weight Loss Drugs Market, By Drug Type, 2021-2029 (USD Million)
83 Rest Of Central & South America Weight Loss Drugs Market, By Application, 2021-2029 (USD Million)
84 Novo Nordisk A/S: Products & Services Offering
85 Eli Lilly & Co.: Products & Services Offering
86 Amgen Inc.: Products & Services Offering
87 Pfizer Inc.: Products & Services Offering
88 Viking Therapeutics Inc.: Products & Services Offering
89 STRUCTURE THERAPEUTICS INC.: Products & Services Offering
90 F. Hoffmann-La Roche Ltd: Products & Services Offering
91 Teva Pharmaceutical Industries Ltd.: Products & Services Offering
92 GlaxoSmithKline plc: Products & Services Offering
93 Sandoz International GmbH: Products & Services Offering
94 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Weight Loss Drugs Market Overview
2 Global Weight Loss Drugs Market Value From 2021-2029 (USD Million)
3 Global Weight Loss Drugs Market Share, By Drug Type (2023)
4 Global Weight Loss Drugs Market Share, By Application (2023)
5 Global Weight Loss Drugs Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Weight Loss Drugs Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Weight Loss Drugs Market
10 Impact Of Challenges On The Global Weight Loss Drugs Market
11 Porter’s Five Forces Analysis
12 Global Weight Loss Drugs Market: By Drug Type Scope Key Takeaways
13 Global Weight Loss Drugs Market, By Drug Type Segment: Revenue Growth Analysis
14 Prescription Market, By Region, 2021-2029 (USD Million)
15 Over-the-counter Market, By Region, 2021-2029 (USD Million)
16 Global Weight Loss Drugs Market: By Application Scope Key Takeaways
17 Global Weight Loss Drugs Market, By Application Segment: Revenue Growth Analysis
18 Appetite Suppression Market, By Region, 2021-2029 (USD Million)
19 Fat Blocking Market, By Region, 2021-2029 (USD Million)
20 Others Market, By Region, 2021-2029 (USD Million)
21 Regional Segment: Revenue Growth Analysis
22 Global Weight Loss Drugs Market: Regional Analysis
23 North America Weight Loss Drugs Market Overview
24 North America Weight Loss Drugs Market, By Drug Type
25 North America Weight Loss Drugs Market, By Application
26 North America Weight Loss Drugs Market, By Country
27 U.S. Weight Loss Drugs Market, By Drug Type
28 U.S. Weight Loss Drugs Market, By Application
29 Canada Weight Loss Drugs Market, By Drug Type
30 Canada Weight Loss Drugs Market, By Application
31 Mexico Weight Loss Drugs Market, By Drug Type
32 Mexico Weight Loss Drugs Market, By Application
33 Four Quadrant Positioning Matrix
34 Company Market Share Analysis
35 Novo Nordisk A/S: Company Snapshot
36 Novo Nordisk A/S: SWOT Analysis
37 Novo Nordisk A/S: Geographic Presence
38 Eli Lilly & Co.: Company Snapshot
39 Eli Lilly & Co.: SWOT Analysis
40 Eli Lilly & Co.: Geographic Presence
41 Amgen Inc.: Company Snapshot
42 Amgen Inc.: SWOT Analysis
43 Amgen Inc.: Geographic Presence
44 Pfizer Inc.: Company Snapshot
45 Pfizer Inc.: Swot Analysis
46 Pfizer Inc.: Geographic Presence
47 Viking Therapeutics Inc.: Company Snapshot
48 Viking Therapeutics Inc.: SWOT Analysis
49 Viking Therapeutics Inc.: Geographic Presence
50 STRUCTURE THERAPEUTICS INC.: Company Snapshot
51 STRUCTURE THERAPEUTICS INC.: SWOT Analysis
52 STRUCTURE THERAPEUTICS INC.: Geographic Presence
53 F. Hoffmann-La Roche Ltd: Company Snapshot
54 F. Hoffmann-La Roche Ltd: SWOT Analysis
55 F. Hoffmann-La Roche Ltd: Geographic Presence
56 Teva Pharmaceutical Industries Ltd.: Company Snapshot
57 Teva Pharmaceutical Industries Ltd.: SWOT Analysis
58 Teva Pharmaceutical Industries Ltd.: Geographic Presence
59 GlaxoSmithKline plc.: Company Snapshot
60 GlaxoSmithKline plc.: SWOT Analysis
61 GlaxoSmithKline plc.: Geographic Presence
62 Sandoz International GmbH: Company Snapshot
63 Sandoz International GmbH: SWOT Analysis
64 Sandoz International GmbH: Geographic Presence
65 Other Companies: Company Snapshot
66 Other Companies: SWOT Analysis
67 Other Companies: Geographic Presence
The Global Weight Loss Drugs Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Weight Loss Drugs Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
